N NUAGE THERAPEUTICS
Live / Registered — Registered (as of 30 Jul 2024)
What this means for you
Registered since 30 Jul 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79369882
- Registration number
- 7459221
- Mark type
- Design + words
- Filed
- 25 Nov 2022
- Published for opposition
- 14 May 2024
- Registered
- 30 Jul 2024
- Attorney of record
- Lawrence Apolzon
Goods and services
- Class 001 — Chemicals: Chemicals for use in product development in the fields of science, scientific research and for laboratory use; in vitro analytical and diagnostic reagents for scientific use
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for targeting of disordered proteins; chemical, analytical and diagnostic reagents for in vitro medical or veterinary use; chemical reagents for medical use; chemical reagents for use in medical or veterinary diagnostics; pharmaceutical preparations for use in the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of ophthalmic diseases and conditions and for the treatment of inflammation and inflammatory conditions and disorders; pharmaceutical preparations for the treatment of metabolic diseases and disorders; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical products for the prevention and treatment of immune-related, neurological and neurodegenerative diseases
- Class 040 — Treatment of materials: Custom manufacture of cell lines for use in the manufacture of biopharmaceutical products; custom manufacture of proteins for third parties; custom manufacture of medicines; custom manufacture of biopharmaceuticals
- Class 042 — Scientific and technological services: Scientific, medical, and medical industrial research and development services; medical clinical research studies; laboratory medical research; research and development of new drugs and medical clinical products; analysis of materials; chemical analysis; medical and scientific laboratory services; laboratory medical testing services; medical laboratory services; information and advisory services relating to the aforesaid, including such services provided online from a computer network or via the internet; research and development services for pharmaceutical preparations and for the treatment of diseases and injuries; genetic engineering services; genetic research for scientific or medical purposes; scientific research and development; scientific research in the field of genetics; medical and pharmacological research services; research and development in the fields of biotechnology, biopharmaceuticals, and gene therapies; medical and scientific research, namely conducting clinical trials; research and development of pharmaceutical products; research and development of vaccines and medicines; stem cell research; research and development in the fields of microorganisms and cells; research in the field of gene therapies; advisory services relating to gene therapy research; biological research, clinical medical research and medical research; product development; biological product development services; consultancy relating to pharmaceutical research and development; providing scientific information in the field of medical disorders and their treatment; pharmaceutical research and development; scientific services relating to the isolation and cultivation of human tissues and cells; research related to molecular science; analysis in the field of molecular biology; research services relating to molecular sciences
Owner
Prosecution history
- 15 Feb 2025 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 27 Jan 2025 — FINAL DISPOSITION NOTICE SENT TO IB
- 27 Jan 2025 — FINAL DISPOSITION PROCESSED
- 30 Oct 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 30 Jul 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 30 Jul 2024 — REGISTERED-PRINCIPAL REGISTER
- 14 May 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 May 2024 — PUBLISHED FOR OPPOSITION
- 24 Apr 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Apr 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 28 Mar 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 27 Mar 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 27 Mar 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 17 Oct 2023 — REFUSAL PROCESSED BY IB
- 27 Sept 2023 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB